48
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      ENaC-mediated alveolar fluid clearance and lung fluid balance depend on the channel-activating protease 1

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sodium transport via epithelial sodium channels (ENaC) expressed in alveolar epithelial cells (AEC) provides the driving force for removal of fluid from the alveolar space. The membrane-bound channel-activating protease 1 (CAP1/ Prss8) activates ENaC in vitro in various expression systems. To study the role of CAP1/ Prss8 in alveolar sodium transport and lung fluid balance in vivo, we generated mice lacking CAP1/ Prss8 in the alveolar epithelium using conditional Cre-loxP-mediated recombination. Deficiency of CAP1/ Prss8 in AEC induced in vitro a 40% decrease in ENaC-mediated sodium currents. Sodium-driven alveolar fluid clearance (AFC) was reduced in CAP1/ Prss8-deficient mice, due to a 48% decrease in amiloride-sensitive clearance, and was less sensitive to β 2-agonist treatment. Intra-alveolar treatment with neutrophil elastase, a soluble serine protease activating ENaC at the cell surface, fully restored basal AFC and the stimulation by β 2-agonists. Finally, acute volume-overload increased alveolar lining fluid volume in CAP1/ Prss8-deficient mice. This study reveals that CAP1 plays a crucial role in the regulation of ENaC-mediated alveolar sodium and water transport and in mouse lung fluid balance.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits.

          The amiloride-sensitive epithelial sodium channel constitutes the rate-limiting step for sodium reabsorption in epithelial cells that line the distal part of the renal tubule, the distal colon, the duct of several exocrine glands, and the lung. The activity of this channel is upregulated by vasopressin and aldosterone, hormones involved in the maintenance of sodium balance, blood volume and blood pressure. We have identified the primary structure of the alpha-subunit of the rat epithelial sodium channel by expression cloning in Xenopus laevis oocytes. An identical subunit has recently been reported. Here we identify two other subunits (beta and gamma) by functional complementation of the alpha-subunit of the rat epithelial Na+ channel. The ion-selective permeability, the gating properties and the pharmacological profile of the channel formed by coexpressing the three subunits in oocytes are similar to that of the native channel.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice.

            The amiloride-sensitive epithelial sodium channel, ENaC, is a heteromultimeric protein made up of three homologous subunits (alpha, beta and gamma) (1,2). In vitro, assembly and expression of functional active sodium channels in the Xenopus oocyte is strictly dependent on alpha-ENaC--the beta and gamma subunits by themselves are unable to induce an amiloride-sensitive sodium current in this heterologous expression system (2). In vivo, ENaC constitutes the limiting step for sodium absorption in epithelial cells that line the distal renal tubule, distal colon and the duct of several exocrine glands. The adult lung expresses alpha, beta and gamma ENaC (3,4), and an amiloride-sensitive electrogenic sodium reabsorption has been documented in upper and lower airways (3-7), but it is not established whether this sodium transport is mediated by ENaC in vivo. We inactivated the mouse alpha-ENaC gene by gene targeting. Amiloride-sensitive electrogenic Na+ transport was abolished in airway epithelia from alpha-ENaC(-/-) mice. Alpha-ENaC(-/-) neonates developed respiratory distress and died within 40 h of birth from failure to clear their lungs of liquid. This study shows that ENaC plays a critical role in the adaptation of the newborn lung to air breathing.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.

              Experimental data suggest that manipulation of alveolar fluid clearance with beta-agonists can accelerate the resolution of alveolar edema and improve survival. To determine if a sustained infusion of intravenous salbutamol (albuterol) would accelerate the resolution of alveolar edema in adult patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). This was a single-center, double-blind, randomized controlled trial. Patients with ALI/ARDS were randomized to treatment with intravenous salbutamol (15 microg kg(-1) h(-1)) or placebo for 7 d. The primary endpoint was extravascular lung water measured by thermodilution (PiCCO) at Day 7. Sixty-six patients were screened; of these, 40 met the inclusion criteria and were enrolled during 2001-2003. Patients in the salbutamol group had significantly lower lung water at Day 7 than the placebo group (9.2 +/- 6 vs. 13.2 +/- 3 ml kg(-1); 95% confidence interval difference, 0.2-8.3 ml kg(-1); p = 0.038). Plateau airway pressure was lower at Day 7 in the salbutamol group (23.9 +/- 3.8 cm H2O) versus placebo (29.5 +/- 7.2 cm H2O; p = 0.049). There was a trend toward lower Murray lung injury score at Day 7 in the salbutamol group (1.7 +/- 0.9) versus placebo (2.0 +/- 0.6; p = 0.2). Patients in the salbutamol group had a higher incidence of supraventricular arrhythmias (26 vs. 10%; p = 0.2). Although further research is required to confirm the efficacy and safety of intravenous salbutamol in ALI/ARDS, this trial provides the first proof of principle that, in humans with ALI/ARDS, sustained treatment with intravenous beta-agonists reduces extravascular lung water.
                Bookmark

                Author and article information

                Journal
                EMBO Mol Med
                EMBO Mol Med
                emmm
                EMBO Molecular Medicine
                WILEY-VCH Verlag (Weinheim )
                1757-4676
                1757-4684
                January 2010
                : 2
                : 1
                : 26-37
                Affiliations
                [1 ]simpleDépartement de Pharmacologie et de Toxicologie, Université de Lausanne Lausanne, Switzerland
                [2 ]simpleINSERM, U773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3, Paris, France
                [3 ]simpleEA 2363, Université Paris 13 Bobigny, France
                [4 ]simpleUniversité Denis Diderot – Paris 7 Paris, France
                [5 ]simpleDebiopharm SA Lausanne, Switzerland
                [6 ]simpleINSERM U700, Paris, France
                Author notes
                * Corresponding author: Tel: +41 21 692 5357; Fax: +41 21 692 53 55; E-mail: edith.hummler@ 123456unil.ch
                [†]

                Carole Planès and Nadia H. Randrianarison contributed equally to this study.

                Article
                10.1002/emmm.200900050
                3377187
                20043279
                677453d6-1be5-40b4-8f03-7cffc0ae517e
                Copyright © 2010 EMBO Molecular Medicine
                History
                : 21 April 2009
                : 26 August 2009
                : 07 September 2009
                Categories
                Research Articles

                Molecular medicine
                elastase,alveolar epithelium,sodium channel,prostasin,β-agonist
                Molecular medicine
                elastase, alveolar epithelium, sodium channel, prostasin, β-agonist

                Comments

                Comment on this article